Product BrochuresLife Sciences
Search results for "rigaku"
Results per page
25
10000 Results Found | Selected Filters:
Application NoteLife Sciences
Illumina DNA Prep
Application NoteLife Sciences
Illumina 5-Base DNA Prep
Product NewsDrug Discovery & Development
Aptamer Group launches targeted radiopharmaceutical program
Three therapeutic targets selected across high‑value clinical indications pipeline planned for four radiotherapy assets with in vivo data expected by end of 2026
Application NoteDrug Discovery & Development
Advancing automated dissolution testing
Application NoteLife Sciences
Infinium Global Screening Array-24 v3.0 BeadChip
Application NoteLife Sciences
Illumina DNA Prep chemistry
Application NoteLife Sciences
iScan System
Industry NewsDrug Discovery & Development
ELRIG announces Prof Hazel Screen and Dr. Dave Powell as keynote speakers for advances in Cell-based Screening 2026
Programme to focus on advancement of animal-replacement technologies and transition towards human-first, AI-driven drug discovery
Application NoteLife Sciences
Illumina DNA Prep with Enrichment
Product BrochuresLife Sciences
NextSeq 1000 and NextSeq 2000 Sequencing Systems
Industry NewsClinical Diagnostics
SelectScience offers enhanced Clinical CE Webinar program to lab professionals
Your trusted source for online, expert led clinical CE/CPD activities in 2026
Application NoteClinical Diagnostics
VeriSeq NIPT Solution v2
Editorial ArticleLife Sciences
Embracing AI-assisted flow cytometry to accelerate innovations in patient care
This guest editorial explores how emerging AI tools are significantly enhancing the utility of flow cytometry across life sciences and highlights how industry leaders must work together to overcome challenges
Application NoteLife Sciences
Infinium MethylationEPIC v2.0 BeadChip
Product BrochuresLife Sciences
NovaSeq X and NovaSeq X Plus Sequencing Systems
Industry NewsClinical Diagnostics
Roche receives CE mark for the first IVD immunoassay blood test to identify carriers of ApoE4
The Elecsys ApoE4 test eliminates the need for confirmatory genetic testing in the significant proportion of Alzheimer’s patients who do not carry the ApoE4 variant
























